: I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by ₁-Antitrypsin

Louis W. Heck ¹ and Allen P. Kaplan ¹

¹ From the Allergic Diseases Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014

Unactivated partial thromboplastin antecedent (PTA) has been purified by sequential chromatography of plasma on quaternary aminoethyl Sephadex, sulphoprophyl Sephadex, Sephadex G-150, and passage over an anti-IgG immunoadsorbant. The preparation gave a single band after alkaline disc gel electrophoresis, sodium dodecyl sulfate (SDS) gel electrophoresis and isoelectric focusing in acrylamide gels and was found to have a mol wt of 175,000 by gel filtration, 163,000 by SDS gel electrophoresis, and an isoelectric point of 8.8–9.4 (peak 9.0–9.1). Pre-PTA was activated directly by activated Hageman factor or by Hageman factor prealbumin fragments. Its coagulant activity was inhibited by DFP, soybean trypsin inhibitor and trasylol but not by lima bean trypsin inhibitor or ovomucoid trypsin inhibitor indicating that activated PTA possesses the same inhibition profile utilizing these reagents as does plasma kallikrein. A major plasma inhibitor of activated PTA was found to be a 65,000 mol wt -globulin which was isolated free of ₁-chymotrypsin inhibitor, inter -trypsin inhibitor, ₂-macroglobulin, and the other known inhibitors of activated PTA, the activated first component of complement (C1 INH), and antithrombin III. Its physicochemical properties were identical to ₁-antitrypsin, and it was absent in ₁-antitrypsin-deficient plasma thereby identifying this PTA inhibitor as ₁-antitrypsin.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Patel, S., Berry, L. R., Chan, A. K.C. (2007). Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism. J Biochem 141: 25-35 [Abstract] [Full Text]  
• Navaneetham, D., Jin, L., Pandey, P., Strickler, J. E., Babine, R. E., Abdel-Meguid, S. S., Walsh, P. N. (2005). Structural and Mutational Analyses of the Molecular Interactions between the Catalytic Domain of Factor XIa and the Kunitz Protease Inhibitor Domain of Protease Nexin 2. J. Biol. Chem. 280: 36165-36175 [Abstract] [Full Text]  
• Zhao, M., Abdel-Razek, T., Sun, M.-F., Gailani, D. (1998). Characterization of a Heparin Binding Site on the Heavy Chain of Factor XI. J. Biol. Chem. 273: 31153-31159 [Abstract] [Full Text]  
• Wuillemin, W. A., Eldering, E., Citarella, F., Ruig, C. P. d., Cate, H. t., Hack, C. E. (1996). Modulation of Contact System Proteases by Glycosaminoglycans. SELECTIVE ENHANCEMENT OF THE INHIBITION OF FACTOR XIa. J. Biol. Chem. 271: 12913-12918 [Abstract] [Full Text]  
• Baglia, F. A., Walsh, P. N. (2000). Thrombin-mediated Feedback Activation of Factor XI on the Activated Platelet Surface Is Preferred over Contact Activation by Factor XIIa or Factor XIa. J. Biol. Chem. 275: 20514-20519 [Abstract] [Full Text]  
• Knauer, D. J., Majumdar, D., Fong, P.-C., Knauer, M. F. (2000). SERPIN Regulation of Factor XIa. THE NOVEL OBSERVATION THAT PROTEASE NEXIN 1 IN THE PRESENCE OF HEPARIN IS A MORE POTENT INHIBITOR OF FACTOR XIa THAN C1 INHIBITOR. J. Biol. Chem. 275: 37340-37346 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS